Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

Autor:	S Tempelaar, S Stephens, Jan S. A. G. Schouten
Rok vydání:	2015
Předmět:	medicine.medical_specialty Cost effectiveness business.industry Health Policy Ophthalmology Wet age-related macular degeneration Public Health Environmental and Occupational Health medicine Ranibizumab business health care economics and organizations Aflibercept medicine.drug
Zdroj:	Value in Health. 18:A420
ISSN:	1098-3015
DOI:	10.1016/j.jval.2015.09.554
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a37b3eab0c391d43a6d7a895addc555 https://doi.org/10.1016/j.jval.2015.09.554 Zobrazit plný text záznamu Full Text from ScienceDirect